ATE236156T1 - Pyridocarbazol derivate die einen cgmp-pde inhibilierenden effekt haben - Google Patents
Pyridocarbazol derivate die einen cgmp-pde inhibilierenden effekt habenInfo
- Publication number
- ATE236156T1 ATE236156T1 AT97924255T AT97924255T ATE236156T1 AT E236156 T1 ATE236156 T1 AT E236156T1 AT 97924255 T AT97924255 T AT 97924255T AT 97924255 T AT97924255 T AT 97924255T AT E236156 T1 ATE236156 T1 AT E236156T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- pct
- cgmp
- pyridocarbazole
- pde
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16073196 | 1996-05-31 | ||
PCT/JP1997/001829 WO1997045427A1 (fr) | 1996-05-31 | 1997-05-29 | DERIVES DE PYRIDOCARBAZOLE AYANT UN EFFET INHIBITEUR DE cGMP-PDE |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE236156T1 true ATE236156T1 (de) | 2003-04-15 |
Family
ID=15721249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97924255T ATE236156T1 (de) | 1996-05-31 | 1997-05-29 | Pyridocarbazol derivate die einen cgmp-pde inhibilierenden effekt haben |
Country Status (8)
Country | Link |
---|---|
US (2) | US6018046A (de) |
EP (1) | EP0985671B1 (de) |
KR (1) | KR20000010919A (de) |
AT (1) | ATE236156T1 (de) |
CA (1) | CA2256889A1 (de) |
DE (1) | DE69720542D1 (de) |
TW (1) | TW422837B (de) |
WO (1) | WO1997045427A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL132993A0 (en) * | 1997-05-29 | 2001-03-19 | Mochida Pharm Co Ltd | Therapeutic agent for erection failure |
WO1999026946A1 (fr) * | 1997-11-26 | 1999-06-03 | Mochida Pharmaceutical Co., Ltd. | DERIVES DE PYRIDOCARBAZOLE A ACTIVITE INHIBITRICE SUR LA cGMP-PDE |
ZA9810766B (en) * | 1997-11-28 | 1999-05-25 | Mochida Pharm Co Ltd | Novel compounds having cgmp-pde inhibitory activity |
CA2353613A1 (en) * | 1998-12-02 | 2000-06-08 | Shigeharu Suzuki | Preparations for intraurethral administration |
GB9828340D0 (en) * | 1998-12-22 | 1999-02-17 | Novartis Ag | Organic compounds |
US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
TWI222450B (en) | 1999-07-28 | 2004-10-21 | Upjohn Co | Oxazinocarbazoles for the treatment of CNS diseases |
TWI224966B (en) * | 1999-11-02 | 2004-12-11 | Pfizer | Pharmaceutical composition (I) useful for treating or preventing pulmonary hypertension in a patient |
UA74826C2 (en) | 2000-05-17 | 2006-02-15 | Ortho Mcneil Pharm Inc | ?-carboline derivatives as phosphodiesterase inhibitors |
WO2002020058A1 (fr) * | 2000-09-06 | 2002-03-14 | Tanabe Seiyaku Co., Ltd. | Preparations administrees par voie orale |
DE10118306A1 (de) * | 2001-04-12 | 2002-10-17 | Bayer Ag | Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation |
US6932961B1 (en) | 2002-04-16 | 2005-08-23 | Pharmacia & Upjohn Company | Oxazinocarbazoles for the treatment of CNS diseases |
DE60326723D1 (de) * | 2002-06-10 | 2009-04-30 | Mondobiotech Licensing Out Ag | Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose |
AU2005224043B2 (en) | 2004-03-05 | 2010-06-24 | Takeda Gmbh | Novel use for PDE5 inhibitors |
US7662831B2 (en) * | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
FR2934595B1 (fr) * | 2008-07-29 | 2013-04-05 | Biomerieux Sa | Reactifs de marquage ayant un noyau pyridine portant une fonction diazomethyle, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques |
AU2013305591B2 (en) | 2012-08-24 | 2017-04-13 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
US10396294B2 (en) | 2013-12-27 | 2019-08-27 | Samsung Electronics Co., Ltd. | Carbazole compound and organic light-emitting device including the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9114760D0 (en) * | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
GB9126260D0 (en) * | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
-
1997
- 1997-05-29 AT AT97924255T patent/ATE236156T1/de not_active IP Right Cessation
- 1997-05-29 US US09/000,402 patent/US6018046A/en not_active Expired - Fee Related
- 1997-05-29 CA CA002256889A patent/CA2256889A1/en not_active Abandoned
- 1997-05-29 DE DE69720542T patent/DE69720542D1/de not_active Expired - Lifetime
- 1997-05-29 KR KR1019980709067A patent/KR20000010919A/ko not_active Application Discontinuation
- 1997-05-29 TW TW086107328A patent/TW422837B/zh not_active IP Right Cessation
- 1997-05-29 EP EP97924255A patent/EP0985671B1/de not_active Expired - Lifetime
- 1997-05-29 WO PCT/JP1997/001829 patent/WO1997045427A1/ja active IP Right Grant
-
1999
- 1999-09-10 US US09/393,376 patent/US6197768B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1997045427A1 (fr) | 1997-12-04 |
TW422837B (en) | 2001-02-21 |
CA2256889A1 (en) | 1997-12-04 |
US6197768B1 (en) | 2001-03-06 |
DE69720542D1 (de) | 2003-05-08 |
EP0985671A4 (de) | 2001-07-25 |
US6018046A (en) | 2000-01-25 |
EP0985671B1 (de) | 2003-04-02 |
KR20000010919A (ko) | 2000-02-25 |
EP0985671A1 (de) | 2000-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE236156T1 (de) | Pyridocarbazol derivate die einen cgmp-pde inhibilierenden effekt haben | |
ES2161785T3 (es) | Emplasto para el tratamiento de micosis ungulares. | |
TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
GB0225475D0 (en) | Therapeutic agents | |
NO976048L (no) | Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser | |
NO20001483L (no) | Nye NPY-agonister | |
DE69431601D1 (de) | Neue verwendung von dexmedetomidin | |
UA35584C2 (uk) | Лікарський засіб для лікування або профілактики ішемії міокарда та спосіб лікування ішемії міокарда у ссавців | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
ATE421329T1 (de) | Verwendung von aplidine zur behandlung von kardiovaskulären erkrankungen | |
DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
DK0888327T3 (da) | Benzopyranderivater, som har antagonistisk virkning imod leukotriener | |
DE69831409D1 (de) | Chalcon-derivate mit antiproliferativer aktivität | |
FI973221A0 (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
BR9815070A (pt) | Compostos tendo efeito inibitório da cgmp-pde | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
ATE332688T1 (de) | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DK0891326T3 (da) | Nye D-vitaminanaloger | |
GR3036023T3 (en) | Substituted phenyl amidines, medicaments containing these compounds and process for producing them | |
ATE172118T1 (de) | Verwendung von östriol zur herstellung einen transdermalen therapeutischen systeme zur behandlung von klimakterischer osteoporose | |
GR3032531T3 (en) | Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases | |
ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |